Søgning
Søgning på udtrykket 'hepatitis b' giver 49 resultater
Dokumenter [4] Sider [4] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [4]
Udarbejdet af arbejdsgruppe fra Dansk Selskab for Infektionsmedicin og Dansk Fertilitetsselskab.
Version 9. Udarbejdet af en arbejdsgruppe nedsat af Dansk Selskab for Infektionsmedicin og Dansk Selskab for Gastroenterologi og Hepatologi.
[…] biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner. Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk […]
Program og tilmelding
Sider [4]
[…] Peer Brehm Christensen, Nina Weis, Britta Tarp, Lone Mygind National Strategi for Hepatitis C (Sundhedsstyrelsen 2023) Kronisk viral hepatitis Nina Weis (tovholder), Peer Brehm Christensen, Alex Lund Laursen Hepatitis B Hepatitis C HIV Antiretroviral terapi Jan Gerstoft (tovholder), Jens Lundgren, Henrik Nielsen, Alex Laursen, Niels Obel, Isik Somuncu, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smittede personer Fertilitetsbehandling ved HIV og hepatitis B og C HIV […]
[…] B, 9. udgave, januar 2025 Genveje Hepatitis B quickguide Hepatitis B oversigt Introduktion Forløb Opfølgning Behandling Bilag Referencer Om denne guideline Quickguide Der anbefales risikobaseret screening til personer med øget risiko eller sårbarhed for hepatitis B Ved mistanke om akut hepatitis B anbefales screening ved hjælp af følgende: HBsAg og evt. IgM Anti-HBc Ved mistanke om kronisk hepatitis B anbefales screening ved hjælp af følgende: HBsAg (og forud for […]
[…] for: Hepatitis A+B+C Syfilis Biomarkørundersøgelser (blodprøve): Hæmatologi, levertal og nyre- væsketal. Ved negativ Hepatitis A og/eller B serologi bør tilbydes vaccination. Patienter, der er Hepatitis B positive, tilbydes også behandling med PrEP, men det skærpes, at behandlingen med PrEP kun ophører, hvis dette er aftalt med en læge, da der er risiko for, at der sker en opblussen af virussen. Det anbefales, at tilbyde vaccination mod MPOX. Hvis en patient ikke er HPV-vaccineret, men opfylder […]
[…] Nina Weis kommenterer: Kronisk hepatitis B, forårsaget af forekomst af hepatitis B virus i blodet i > 6 måneder, kan klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom. Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark. Aktuelt er eneste behandlingstilbud (ofte livslang) antiviral terapi. Denne artikel gennemgår naturhistorien, kendte og nye biomarkører, […]
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
10. november 2025
[…] The widespread application of interleukin (IL) inhibitors for various conditions, including gastrointestinal, rheumatologic, dermatologic and pulmonary diseases, has raised concerns regarding the potential for hepatitis B virus reactivation (HBVr). However, the precise risk of HBVr remains unclear due to inconsistencies in existing research. This systematic review aims to quantify the risk of HBVr in patients receiving IL inhibitor therapies. Methods and analysis This systematic review will […]
Nature
7. november 2025
Antimicrobial Agents And Chemotherapy
6. november 2025
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Antimicrobial Agents And Chemotherapy
4. november 2025
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Journal of Medical Virology
3. november 2025
Journal of Medical Virology, Volume 97, Issue 11, November 2025.
Journal of Medical Virology
31. oktober 2025
Journal of Medical Virology, Volume 97, Issue 11, November 2025.
BMC Infectious Diseases
31. oktober 2025
[…] Despite extensive HBV vaccination efforts in Indonesia, the prevalence of occult hepatitis B virus infection (OBI) remains a concern, particularly among blood donors. This study investigated the prevalence of OBI, the distribution of circulating HBV genotypes, seropositivity for HBV-specific antibodies, and the potential influence of mutational characteristics on HBsAg secretion among blood donors in Jember, Indonesia. Methods A total of 330 HBsAg-negative blood donor samples from the Indonesian […]
International Journal of Infectious Diseases
30. oktober 2025
[…] annually—are due to a liver-related disease [1]. Complex aetiologies with both infectious and non-communicable causes can lead to common liver diseases including liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC) [2–6]. Two leading causes of liver disease in low-income countries, in particular as related to liver fibrosis, are intestinal schistosomiasis (caused by helminths of the species Schistosoma mansoni, S. japonicum, and S. mekongi) and viral infections with hepatitis B (HBV) and C […]
Journal of Infectious Diseases
30. oktober 2025
[…] with chronic hepatitis B (CHB) may harbor occult yet significant liver pathology despite normal alanine aminotransferase (ALT) levels, representing a major diagnostic challenge. We aimed to identify and validate non-invasive biomarkers for detecting significant liver pathology among these population.MethodsThis multicenter study screened 3,258 CHB cases from 2013-2023, enrolling 137 treatment-naïve HBeAg+ and 253 HBeAg− infection patients with normal ALT (≤40 U/L). All […]
Journal of Medical Virology
29. oktober 2025
Journal of Medical Virology, Volume 97, Issue 11, November 2025.
BMC Infectious Diseases
28. oktober 2025
[…] HIV/HBV co-infection accelerates the progression of chronic hepatitis towards end-stage liver disease. In Togo, little is known about the prevalence of hepatitis B in people living with HIV (PLWH). The objective of this study was to estimate the determinants of hepatitis B virus (HBV) infection among PLWH in Togo in 2023. Methods A cross-sectional study was carried out between May and October 2023 among PLWH receiving antiretroviral treatment in HIV care centers in the six health regions of Togo. […]
PLoS One Infectious Diseases
28. oktober 2025
[…] stem cell transplant (HSCT) recipients, although relatively few studies have evaluated immunogenicity in adults. We therefore aimed to assess the immune response in adult allogeneic HSCT recipients vaccinated against tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b. Method We conducted a multicenter prospective study. HSCT recipients were included at least 6 months post-transplantation (maximum: 24 months) if blood CD19 + lymphocytes were ≥0.1 G/L and plasma immunoglobulin ≥ […]
BMC Infectious Diseases
22. oktober 2025
[…] and aims Hepatitis B (HBV) poses a significant public health challenge in Malawi with a pooled prevalence of 8% in the general population. This study aimed to determine the prevalence of HBV infection among healthcare workers in Salima District, Malawi, and assess the severity of positive cases. Methods In September 2020, a cross-sectional study was conducted in all public health facilities across Salima District and screened 854 healthcare workers for hepatitis B virus (HBV) using antigen […]
International Journal of Infectious Diseases
18. oktober 2025
The occult HBV infection (OBI) is a state in which replication-competent HBV DNA continuously exists in the livers of individuals whose serum HBsAg is negative via existing laboratory techniques. Their serum HBV DNA quantification is sporadically positive at low concentrations [1]. The European Association for the Study of the Liver characterized OBI as a new phase of chronic hepatitis B (CHB) [2].
Journal of Medical Virology
16. oktober 2025
Journal of Medical Virology, Volume 97, Issue 10, October 2025.
BMC Infectious Diseases
15. oktober 2025
[…] Tribal communities are disproportionately affected by hepatitis B virus (HBV) compared to non-tribal populations, posing a significant public health concern. This study aimed to assess the prevalence of and risk factors associated with HBV infection among the Irula tribal population in Dharmapuri district, Tamil Nadu, India. Methodology A cross-sectional study was conducted among the Irula tribal population in Tamil Nadu, India. While the survey covered all three districts, blood samples for […]
BMC Infectious Diseases
10. oktober 2025
BMC Infectious Diseases
10. oktober 2025
Journal of Medical Virology
5. oktober 2025
Journal of Medical Virology, Volume 97, Issue 10, October 2025.
BMJ Open
22. september 2025
[…] functional cure of chronic hepatitis B (CHB) is an ideal goal of therapy, as it is associated with improved long-term outcomes. Patients with low levels of HBsAg have higher rates of functional cure by pegylated interferon α (PEG-IFNα) therapy, and similar results have been observed in patients treated with PD-1 antibody. However, the combination therapy of PD-1 antibody and PEG-IFNα for promoting functional cure has not been studied. This study protocol aims to evaluate the efficacy and […]
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
11. september 2025
HBV immunity induced by vaccination may protect against diabetes, with greater protection in younger people and those with higher levels of immunity, new data suggest. Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
8. august 2025
This report describes acute hepatitis B infection in a nursing home resident who used a shared glucometer that was also used on a resident with chronic hepatitis B.
Eurosurveillance latest updates
26. juli 2025
[…] with World Health Organization (WHO) goals, Ukraine aims to eliminate viral hepatitis. While some data on viral hepatitis B and C prevalence exist among key populations, nationwide prevalence in the general population has never been assessed. AIMTo assess the prevalence of viral hepatitis B, C, and D seromarkers in Ukraine in 2021 to plan and monitor elimination measures. METHODSBlood samples available from a cross-sectional household-based SARS-CoV-2 serosurvey conducted in 2021 were […]
Medscape Infectious Diseases
13. juni 2025
A retrospective analysis of a privately insured US database found many chronic hepatitis B cases are diagnosed incidentally during the work-up for liver complications. Medscape Medical News
ProMED
14. marts 2025
[…] B - AUSTRALIA: (NEW SOUTH WALES) POSSIBLE TRANSMISSION RISK,BIRTH UNIT, 2013-2024********************************************************************************************A ProMED-mail postwww.promedmail.orgProMED-mail is a program of theInternational Society for Infectious Diseaseswww.isid.org Date: Tue 11 Mar 2025 Source: 9 News [edited] […]
ProMED
11. marts 2025
[…] B - MAURITANIA: PREVALENCE, MOH, 2022-2023****************************************************A ProMED-mail postwww.promedmail.orgProMED-mail is a program of theInternational Society for Infectious Diseaseswww.isid.org Date: Tue 4 Mar 2025 Source: Aqlame [in Arabic, trans. & summ. Mod.MM, edited] aqlame.com/node/36018 The director-general of Hepatology and Virology Hospital, Mauritania,has revealed that more than half a million persons in the country areat risk of hepatitis […]
Eurosurveillance latest updates
21. februar 2025
[…] 2009, European guidelines recommend individuals with hepatitis B virus (HBV) and HIV be tested for hepatitis D virus (HDV). AimTo analyse HDV testing in individuals with HBV/HIV during routine practice in the Netherlands. MethodsWe assessed data from the ATHENA cohort of people with HIV who were ever HBV surface antigen-positive, aged ≥ 18 years and attended one of 24 HIV treatment centres in the Netherlands during 2000–22. Using longitudinal analysis, we estimated the percentage of […]
Morbidity and Mortality Weekly Report (MMWR)
5. december 2024
This report describes an update to the recommendation for Hepatitis B vaccination in adults aged 19-59 years.
Medscape Infectious Diseases
1. oktober 2025
The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children. KFF Health News
Medscape Infectious Diseases
23. september 2025
The panel also reverses a vote on MMRV from the prior day and postpones a vote on a birth dose of hepatitis B vaccine. Medscape Medical News
Medscape Infectious Diseases
17. september 2025
A key federal vaccine advisory panel is expected to vote to recommend delaying the hepatitis B vaccine that’s currently given to newborns until the age of 4 years. KFF Health News
Medscape Infectious Diseases
21. august 2025
This toolkit provides prison health teams with concrete steps to curb hepatitis B and C infections in correctional facilities across Europe. Medscape News UK
Medscape Infectious Diseases
20. august 2025
This case highlights the importance of assigning glucose meters to individuals and of vaccination against hepatitis B. Medscape Medical News
Eurosurveillance latest updates
1. august 2025
[…] infectious diseases (DRID), such as HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV), contribute to high morbidity and mortality among people who inject drugs (PWID). The European Union Drugs Agency (EUDA) is responsible for monitoring DRID and related behaviours for PWID in Europe. We updated the EUDA DRID technical protocol which covers all steps from planning to data analysis needed for a survey among PWID. Drug-related infectious disease-specific indicators were revised. To enable […]
Medscape Infectious Diseases
9. juli 2025
Metabolic dysfunction-associated steatotic liver disease is prevalent among patients with chronic hepatitis B in Europe and is linked to an increased risk for fibrosis. Medscape News UK
Medscape Infectious Diseases
5. juni 2025
The shift toward universal screening for diseases like hepatitis C, hepatitis B, and HIV removes part of the burden of identifying risk factors from PCPs. Medscape Medical News
WHO Eastern Mediterranean Region news
3. juni 2025
[…] Vaccine Manufacturers Alliance, Colleagues and Partners, On behalf of the World Health Organization, I extend my warmest congratulations to Egypt for becoming the first country in the Eastern Mediterranean Region to achieve the regional target for hepatitis B control, as set by the Regional Committee Resolution EM/RC56/R.5 (2009). This recognition follows a rigorous review led by the independent Regional Validation Committee (RVC). Based on robust and verifiable data, the RVC concluded that Egypt […]
ProMED
12. april 2025
[…] et al. IJID Regions 2025;14:100495 doi.org/10.1016/j.ijregi.2024.100495 _Helicobacter pylori_ vacA genes associated with gastric diseases inTrinidad and Tobago Unakal et al. IJID Regions 2025;14:100498 doi.org/10.1016/j.ijregi.2024.100498 Hepatitis B and C virus infection among couples undergoing premaritalscreening in Iraqi Kurdistan Naqid et al. IJID Regions 2025;14:100492 doi.org/10.1016/j.ijregi.2024.100492 Clinical epidemiology, genetic diversity and drug […]
ProMED
10. april 2025
[…] in Konaseema district [Andhra Pradesh] havereported a spike in hepatitis infections in Pallam village, followingover 10 days of persistent fever cases and illness among residents. District Medical and Health Officer (DMHO) Dr Durga Rao Dora confirmed19 Hepatitis B Surface Antigen (HBSAG) cases and 9 Hepatitis C Virus(HCV) infections after a large-scale screening of over 2300 residents.He said the cluster warranted special attention and assured thatmedical teams were monitoring the situation and taking […]
ProMED
1. april 2025
[…] programme on HIV/AIDS involving principals of 220schools where intravenous drug practices were identified. In January[2025], the government also held integrated health campaigns in WestTripura district to test and identify the HIV/hepatitis B/hepatitisC/syphilis cases among the vulnerable groups [and] displayed messageson HIV/AIDS and drug abuse on huge LED screens in the state as part ofmass awareness, he added. Besides, 3 new satellite opioid substitution therapy centres have […]